EN
HI
Kobo Biotech Chart
Kobo Biotech Share Key Metrics
Volume
24532.00
Market Cap
9.84 CR
LTQ@LTP
9@4.33
ATP
4.33
Var Margin
100 %
Circuit Range
3.93-4.33
Delivery %
100 %
Value
1.06 L
ASM/GSM
No
Market Lot
1
Summary
Kobo Biotech share price is ₹4.33 as of 2 Jun, 2026. The stock Kobo Biotech intraday movement has stayed between ₹4.33 and ₹4.33, while on a 52-week basis,Kobo Biotech price 52 week high is ₹4.33 & its 52 week low is ₹1.99.
In terms of trading activity, Kobo Biotech has recorded a volume of 24532 shares, The Kobo Biotech has a market cap of ₹23825000 CR. The stock’s Average Traded Price (ATP) stands at ₹4.33, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9 @ ₹4.33.
Kobo Biotech operates within a circuit range of ₹3.93 – ₹4.33, with a Value of ₹1.06 L. The Delivery Percentage for the day is 100%. Additionally, Kobo Biotech currently falls under the No framework, and trades with a market lot size of 1.
Kobo Biotech Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.94
Sector P/B
2.97
Sec. Div. Yield
0.55
Kobo Biotech Resistance and Support
Pivot 4.13
Resistance
First Resistance
4.13
Second Resistance
4.13
Third Resistance
4.13
Support
First Support
4.13
Second Support
4.13
Third Support
4.13
Kobo Biotech Corporate Actions
| Date | Agenda | |||
|---|---|---|---|---|
 | ||||
Kobo Biotech News
Kobo Biotech Ltd-$ - 531541 - Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
NCLT approved Kobo Biotech's resolution plan on May 11, 2026, with Beaufond Industries as the successful resolution applicant. The plan involves INR 70.11 crore payout to creditors, but significantly dilutes existing public shareholders to a 2% stake.
May 13 2026 11:11:25
Kobo Biotech Ltd-$ - 531541 - Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
NCLT Hyderabad has approved the resolution plan for Kobo Biotech Ltd, submitted by Beaufond Industries Limited. The plan involves acquiring Kobo Biotech as a going concern, a capital reduction, and a composite scheme for restructuring and revival of operations, with a total outlay of Rs.70.11 crores.
May 11 2026 19:33:44
Kobo Biotech Management
| Name | Position |
|---|---|
| Ajit Kamath | Chairman |
| Rajendra Kaimal | Non Executive Director |
Kobo Biotech Similar Stocks
Unjha Formulations Ltd.
19.50
0.00 (0.00%)
Ortin Global Ltd.
14.43
0.00 (0.00%)
Hindustan Bio Sciences Ltd.
7.83
-0.39 (4.74%)
Dolphin Medical Services Ltd.
7.52
0.00 (0.00%)
Kabra Drugs Ltd.
23.86
0.95 (4.15%)
Clinitech Laboratory Ltd.
37.80
0.00 (0.00%)
Dhanvantri Jeevan Rekha Ltd.
19.70
0.00 (0.00%)
Dr Lalchandani Labs Ltd.
9.97
0.00 (0.00%)
Transpact Enterprises Ltd.
200.00
0.00 (0.00%)
Kobo Biotech FAQs
The Buying Price of Kobo Biotech share is 4.33 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kobo Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kobo Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kobo Biotech shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kobo Biotech shares is 0. Useful to assess the stock's value relative to its book value.
To assess Kobo Biotech’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kobo Biotech is 9.84 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kobo Biotech share price is 4.33 & 1.99. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kobo Biotech belongs to the Healthcare sector.
